Company profile: Medicinal Genomics
1.1 - Company Overview
Company description
- Provider of genomics-driven testing and breeding solutions for medical cannabis and hemp, including the PathoSEEK qPCR-based microbial safety testing platform and detection assays for flower, extracts, and infused products; SenSATIVAx DNA purification kits; FemINDICAtor qPCR plant sex testing; and genomic services to identify markers for desirable traits and accelerate breeding programs.
Products and services
- PathoSEEK Microbial Safety Testing Platform: A qPCR-based microbial testing method engineered for cannabis matrices, offering accurate, scalable, efficient detection of microbial contamination in regulated cannabis workflows
- PathoSEEK Detection Assays: qPCR assays specifically architected for cannabis and hemp products—including flower, extracts, and infused products—to detect microbial contamination across specified sample types
- Genomic Services for Cannabis Breeding: Genomic-marker–guided services that identify specific genomic markers associated with desirable traits in cannabis, accelerating breeding programs.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medicinal Genomics
DNAfit
HQ: United Kingdom
Website
- Description: Provider of at-home DNA testing and genetic insights for health, fitness, and nutrition. Offerings include CircleDNA Premium (500+ reports via saliva swab), genetic carrier screening, disease and cancer risk overviews, diet and fitness reports, skin predisposition insights, and success trait summaries to help personalize exercise, nutrition, and skincare choices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DNAfit company profile →
Senti Bio
HQ: United States
Website
- Description: Provider of synthetic biology-driven cell and gene therapies for cancer, featuring a Gene Circuit platform to program therapies, off-the-shelf CAR-NK cell therapies, and investigational candidates SENTI-202 (logic-gated targeting of CD33/FLT3 for hematologic malignancies incl. AML) and SENTI-301A (for GPC3+ tumors with crIL-15 Gene Circuit), with manufacturing via GeneFab.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Senti Bio company profile →
CosmosID
HQ: United States
Website
- Description: Provider of metagenomics and bioinformatics services for rapid identification of microorganisms in various samples, offering strain-level analysis via proprietary pipeline and database to detect bacteria, viruses, fungi, and more. Provides sequencing services (amplicon, shallow/deep shotgun, bacterial isolate) and CosmosID-HUB Microbiome, an online platform with pipelines for amplicon and shotgun data, plus targeted tests and whole genome analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CosmosID company profile →
Codexis
HQ: United States
Website
- Description: Provider of enzyme discovery and RNA manufacturing solutions, offering the CodeEvolver platform to discover, develop, and enhance novel enzymes and proteins; ECO Synthesis technology for scaled enzymatic production of RNAi therapeutics; custom enzymes to improve small molecule pharmaceutical manufacturing; RNA ligase screening and optimization; and high-yield RNA manufacturing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Codexis company profile →
Chromatin
HQ: United States
Website
- Description: Provider of plant breeding and genomics technologies for agricultural, energy, chemical, nutritional and pharmaceutical sectors. Develops sorghum for agriculture and renewable energy, and advances maize and wheat via high-yielding, disease- and climate-resilient traits. Services include genomic selection, high-throughput phenotyping, multi-trait analysis, environics for genotype prediction, and integrated genomics-phenomics modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chromatin company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medicinal Genomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medicinal Genomics
2.2 - Growth funds investing in similar companies to Medicinal Genomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medicinal Genomics
4.2 - Public trading comparable groups for Medicinal Genomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →